These are the 6 top-performing stocks in the Nasdaq-100 with 2024 almost over
Which stocks are leading the Nasdaq-100 higher in 2024? This diverse bunch of leaders is taking the market by storm. The post ...
ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript
ReShape Lifesciences Inc. ( NASDAQ: RSLS) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Michael Miller - Rx Communications Paul Hickey - President and CEO Thomas Stankovich - CFO ...
Why Tesla Stock Was Sliding Today
Shares of Tesla (NASDAQ: TSLA) were heading lower on reports that the Trump administration planned to eliminate the $7,500 ...
Micron Technology, Inc. (NASDAQ:MU) Faces Selling Pressure, Edgewater Issues Bearish DRAM Market Call
We recently compiled a list of the 15 AI News You Must Read Today. In this article, we are going to take a look at where ...
Jim Cramer on monday.com Ltd. (MNDY): ‘They Are As Blessed Now As They Were Cursed Not That Long Ago’
We recently compiled a list of the 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...
Jim Cramer on The Home Depot, Inc. (HD): ‘The Stock, Which Looks Like It’s Up, Could Head Up Much Higher’
We recently compiled a list of the 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where The ...
Navitas Semiconductor Corporation (NASDAQ:NVTS) and Richardson Ink EMEA Deal, Boosting AI-Driven SiC Power Solutions
We recently compiled a list of the 15 AI News You Must Read Today. In this article, we will look at where Navitas ...
Super Micro Stock Could Get Delisted. What to Consider If You Own the Shares.
Super Micro Computer stock could get delisted soon—and investors who own shares must decide whether to continue holding the ...
Stock market today: Indexes fall as Powell says the Fed is in no hurry to cut interest rates
Indexes slipped as traders zeroed in on remarks from Fed Chair Jerome Powell, who said the central bank is in no hurry to cut ...
Stock Market Today: Stocks Slip, Dollar Extends Rally
The dollar is trading at a near two-year high. Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Arcturus: LUNAR-CF For CF Presses On With 1st Half Of 2025 Interim Data
Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.